stoxline Quote Chart Rank Option Currency Glossary
  
(CSL)
  0 (0%)    09-27 11:11
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:46:54 PM
Short term     
Mid term     
Targets 6-month :  435.59 1-year :  470.06
Resists First :  372.93 Second :  402.45
Pivot price 351.45
Supports First :  325.19 Second :  270.55
MAs MA(5) :  332.33 MA(20) :  359.99
MA(100) :  382.24 MA(250) :  387.84
MACD MACD :  -15.3 Signal :  -11.9
%K %D K(14,3) :  3.8 D(3) :  7.4
RSI RSI(14): 31.4
52-week High :  481.26 Low :  311.41
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CSL ] has closed above bottom band by 24.3%. Bollinger Bands are 65.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 331.91 - 334.23 334.23 - 336.01
Low: 319.09 - 322.25 322.25 - 324.68
Close: 323.15 - 327.43 327.43 - 330.71
Company Description

Headline News

Fri, 26 Sep 2025
CSL (OTCMKTS:CSLLY) Shares Gap Down - Here's Why - MarketBeat

Fri, 26 Sep 2025
The BWM Art World Tour to make a stop at Rétromobile 2026 - Old Cars Weekly

Fri, 26 Sep 2025
How Carlisle Companies’ (CSL) Role Supports its Position in Cheap Quarterly Dividend Stocks - Yahoo Finance

Fri, 26 Sep 2025
CSL Behring’s angioedema treatments receives NICE recommendation - Pharmafile

Fri, 26 Sep 2025
Trump tariff announcement wipes $1bn from CSL value – as it happened - The Guardian

Fri, 26 Sep 2025
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 43 (M)
Shares Float 42 (M)
Held by Insiders 1.1 (%)
Held by Institutions 103 (%)
Shares Short 2,770 (K)
Shares Short P.Month 2,560 (K)
Stock Financials
EPS 17.85
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 49.9
Profit Margin 16.1 %
Operating Margin 23.2 %
Return on Assets (ttm) 10.5 %
Return on Equity (ttm) 31.3 %
Qtrly Rev. Growth -0.2 %
Gross Profit (p.s.) 43.27
Sales Per Share 116.95
EBITDA (p.s.) 28.53
Qtrly Earnings Growth -60.5 %
Operating Cash Flow 972 (M)
Levered Free Cash Flow 679 (M)
Stock Valuations
PE Ratio 18.34
PEG Ratio 0
Price to Book value 6.56
Price to Sales 2.8
Price to Cash Flow 14.4
Stock Dividends
Dividend 1.1
Forward Dividend 0
Dividend Yield 0.3%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android